BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Geier A, Wagner M, Dietrich CG, Trauner M. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim Biophys Acta. 2007;1773:283-308. [PMID: 17291602 DOI: 10.1016/j.bbamcr.2006.04.014] [Cited by in Crossref: 225] [Cited by in F6Publishing: 202] [Article Influence: 14.1] [Reference Citation Analysis]
Number Citing Articles
1 Dawson PA. Bile Secretion and the Enterohepatic Circulation. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 1075-1088.e2. [DOI: 10.1016/b978-1-4160-6189-2.00064-0] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
2 Yang H, Plösch T, Lisman T, Gouw ASH, Porte RJ, Verkade HJ, Hulscher JBF. Inflammation Mediated Down-Regulation of Hepatobiliary Transporters Contributes to Intrahepatic Cholestasis and Liver Damage in Murine Biliary Atresia. Pediatr Res 2009;66:380-5. [DOI: 10.1203/pdr.0b013e3181b454a4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cortez LM, Campeau J, Norman G, Kalayil M, Van der Merwe J, McKenzie D, Sim VL. Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease. J Virol 2015;89:7660-72. [PMID: 25972546 DOI: 10.1128/JVI.01165-15] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
4 Acharya P, Nanjaiah L, Singh SA, Talahalli RR. Hyperglycemia exacerbates dyslipidemia-induced changes in uptake, synthesis, and transporters of bile acids in rats: Assessment of restorative potentials of ALA and EPA + DHA. Journal of Functional Foods 2019;54:329-36. [DOI: 10.1016/j.jff.2019.01.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Ma X, Wang J, He X, Zhao Y, Wang J, Zhang P, Zhu Y, Zhong L, Zheng Q, Xiao X. Large dosage of chishao in formulae for cholestatic hepatitis: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2014;2014:328152. [PMID: 24987427 DOI: 10.1155/2014/328152] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
6 Vartak N, Guenther G, Joly F, Damle-Vartak A, Wibbelt G, Fickel J, Jörs S, Begher-Tibbe B, Friebel A, Wansing K, Ghallab A, Rosselin M, Boissier N, Vignon-Clementel I, Hedberg C, Geisler F, Hofer H, Jansen P, Hoehme S, Drasdo D, Hengstler JG. Intravital Dynamic and Correlative Imaging of Mouse Livers Reveals Diffusion-Dominated Canalicular and Flow-Augmented Ductular Bile Flux. Hepatology 2021;73:1531-50. [PMID: 32558958 DOI: 10.1002/hep.31422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Zhang Y, Zhao T, Li W, Vore M. The 5'-untranslated region of multidrug resistance associated protein 2 (MRP2; ABCC2) regulates downstream open reading frame expression through translational regulation. Mol Pharmacol 2010;77:237-46. [PMID: 19890061 DOI: 10.1124/mol.109.058982] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
8 Li F, Liu Y, Huang G, Chiou L, Liang J, Sun T, Dong C, Lee H. In vivo dynamic metabolic imaging of obstructive cholestasis in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 2009;296:G1091-7. [DOI: 10.1152/ajpgi.90681.2008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
9 Basiglio CL, Toledo FD, Sánchez Pozzi EJ, Roma MG. Radical Oxygen Species and Bile Secretion. In: Laher I, editor. Systems Biology of Free Radicals and Antioxidants. Berlin: Springer Berlin Heidelberg; 2014. pp. 1787-808. [DOI: 10.1007/978-3-642-30018-9_140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Muchova L, Vanova K, Zelenka J, Lenicek M, Petr T, Vejrazka M, Sticova E, Vreman HJ, Wong RJ, Vitek L. Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress. J Cell Mol Med 2011;15:1156-65. [PMID: 20518850 DOI: 10.1111/j.1582-4934.2010.01098.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
11 Kim KH, Choi JM, Li F, Arizpe A, Wooton-Kee CR, Anakk S, Jung SY, Finegold MJ, Moore DD. Xenobiotic Nuclear Receptor Signaling Determines Molecular Pathogenesis of Progressive Familial Intrahepatic Cholestasis. Endocrinology 2018;159:2435-46. [PMID: 29718219 DOI: 10.1210/en.2018-00110] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
12 Stephens C, Lucena MI, Andrade RJ. Host Risk Modifiers in Idiosyncratic Drug-Induced Liver Injury (DILI) and Its Interplay with Drug Properties. In: Chen M, Will Y, editors. Drug-Induced Liver Toxicity. New York: Springer; 2018. pp. 477-96. [DOI: 10.1007/978-1-4939-7677-5_23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Amaral JD, Viana RJ, Ramalho RM, Steer CJ, Rodrigues CM. Bile acids: regulation of apoptosis by ursodeoxycholic acid. J Lipid Res. 2009;50:1721-1734. [PMID: 19417220 DOI: 10.1194/jlr.r900011-jlr200] [Cited by in Crossref: 182] [Cited by in F6Publishing: 94] [Article Influence: 14.0] [Reference Citation Analysis]
14 Nies AT. MRP2 (ABCC2) and MRP3 (ABCC3). In: Ishikawa T, Kim RB, König J, editors. Pharmacogenomics of Human Drug Transporters. Hoboken: John Wiley & Sons, Inc.; 2013. pp. 345-64. [DOI: 10.1002/9781118353240.ch15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
15 de Cerio OD, Bilbao E, Cajaraville MP, Cancio I. Regulation of xenobiotic transporter genes in liver and brain of juvenile thicklip grey mullets (Chelon labrosus) after exposure to Prestige-like fuel oil and to perfluorooctane sulfonate. Gene 2012;498:50-8. [PMID: 22343007 DOI: 10.1016/j.gene.2012.01.067] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
16 Prasnicka A, Cermanova J, Hroch M, Dolezelova E, Rozkydalova L, Smutny T, Carazo A, Chladek J, Lenicek M, Nachtigal P, Vitek L, Pavek P, Micuda S. Iron depletion induces hepatic secretion of biliary lipids and glutathione in rats. Biochim Biophys Acta Mol Cell Biol Lipids 2017;1862:1469-80. [PMID: 28888833 DOI: 10.1016/j.bbalip.2017.09.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
17 Hoekstra LT, de Graaf W, Nibourg GA, Heger M, Bennink RJ, Stieger B, van Gulik TM. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg. 2013;257:27-36. [PMID: 22836216 DOI: 10.1097/sla.0b013e31825d5d47] [Cited by in Crossref: 176] [Cited by in F6Publishing: 80] [Article Influence: 19.6] [Reference Citation Analysis]
18 Daly AK. Pharmacogenomics of adverse drug reactions. Genome Med. 2013;5:5. [PMID: 23360680 DOI: 10.1186/gm409] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 7.0] [Reference Citation Analysis]
19 Dietrich CG, Vehr AK, Martin IV, Gassler N, Rath T, Roeb E, Schmitt J, Trautwein C, Geier A. Downregulation of breast cancer resistance protein in colon adenomas reduces cellular xenobiotic resistance and leads to accumulation of a food-derived carcinogen. Int J Cancer. 2011;129:546-552. [PMID: 21544799 DOI: 10.1002/ijc.25958] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
20 Fiorucci S, Baldelli F. Farnesoid X receptor agonists in biliary tract disease. Curr Opin Gastroenterol 2009;25:252-9. [PMID: 19300246 DOI: 10.1097/MOG.0b013e328324f87e] [Cited by in Crossref: 45] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
21 Mooranian A, Raj Wagle S, Kovacevic B, Takechi R, Mamo J, Lam V, Watts GF, Mikov M, Golocorbin-Kon S, Stojanovic G, Al-Sallami H, Al-Salami H. Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study. Sci Rep 2020;10:106. [PMID: 31919411 DOI: 10.1038/s41598-019-53999-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
22 Henkel AS, LeCuyer B, Olivares S, Green RM. Endoplasmic Reticulum Stress Regulates Hepatic Bile Acid Metabolism in Mice. Cell Mol Gastroenterol Hepatol 2017;3:261-71. [PMID: 28275692 DOI: 10.1016/j.jcmgh.2016.11.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
23 Geier A, Martin IV, Dietrich CG, Balasubramaniyan N, Strauch S, Suchy FJ, Gartung C, Trautwein C, Ananthanarayanan M. Hepatocyte nuclear factor-4alpha is a central transactivator of the mouse Ntcp gene. Am J Physiol Gastrointest Liver Physiol 2008;295:G226-33. [PMID: 18483185 DOI: 10.1152/ajpgi.00012.2008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
24 Ghallab A, Hofmann U, Sezgin S, Vartak N, Hassan R, Zaza A, Godoy P, Schneider KM, Guenther G, Ahmed YA, Abbas AA, Keitel V, Kuepfer L, Dooley S, Lammert F, Trautwein C, Spiteller M, Drasdo D, Hofmann AF, Jansen PLM, Hengstler JG, Reif R. Bile Microinfarcts in Cholestasis Are Initiated by Rupture of the Apical Hepatocyte Membrane and Cause Shunting of Bile to Sinusoidal Blood. Hepatology 2019;69:666-83. [PMID: 30102412 DOI: 10.1002/hep.30213] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
25 Bala L, Tripathi P, Choudhuri G, Khetrapal CL. Restoration of hepatocytes function following decompression therapy in extrahepatic biliary obstructed patients: Metabolite profiling of bile by NMR. Journal of Pharmaceutical and Biomedical Analysis 2011;56:54-63. [DOI: 10.1016/j.jpba.2011.04.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
26 Roman DL, Isvoran A, Filip M, Ostafe V, Zinn M. In silico Assessment of Pharmacological Profile of Low Molecular Weight Oligo-Hydroxyalkanoates. Front Bioeng Biotechnol 2020;8:584010. [PMID: 33324621 DOI: 10.3389/fbioe.2020.584010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Merrell MD, Nyagode BA, Clarke JD, Cherrington NJ, Morgan ET. Selective and cytokine-dependent regulation of hepatic transporters and bile acid homeostasis during infectious colitis in mice. Drug Metab Dispos 2014;42:596-602. [PMID: 24378326 DOI: 10.1124/dmd.113.055525] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
28 Thompson MD, Moghe A, Cornuet P, Marino R, Tian J, Wang P, Ma X, Abrams M, Locker J, Monga SP, Nejak-Bowen K. β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis. Hepatology 2018;67:955-71. [PMID: 28714273 DOI: 10.1002/hep.29371] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
29 Trauner M, Fickert P, Halilbasic E, Moustafa T. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases. Wien Med Wochenschr. 2008;158:542-548. [PMID: 18998069 DOI: 10.1007/s10354-008-0592-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 5.6] [Reference Citation Analysis]
30 Li M, Wang W, Soroka CJ, Mennone A, Harry K, Weinman EJ, Boyer JL. NHERF-1 binds to Mrp2 and regulates hepatic Mrp2 expression and function. J Biol Chem 2010;285:19299-307. [PMID: 20404332 DOI: 10.1074/jbc.M109.096081] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
31 Fernández-Murga ML, Petrov PD, Conde I, Castell JV, Goméz-Lechón MJ, Jover R. Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems. Food Chem Toxicol 2018;120:196-212. [PMID: 29990576 DOI: 10.1016/j.fct.2018.07.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Péan N, Doignon I, Tordjmann T. Bile acids and liver carcinogenesis: TGR5 as a novel piece in the puzzle? Clin Res Hepatol Gastroenterol 2013;37:226-9. [PMID: 23434440 DOI: 10.1016/j.clinre.2012.12.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
33 Srivastava S, Roy R, Kumar S, Gupta HO, Singh D, Kushwaha JK, Chandra A, Sonkar AA. Cholesterol and its esters as serum biomarkers in malignant obstructive jaundice: a single step 1H NMR metabolomic approach. Metabolomics 2013;9:1181-91. [DOI: 10.1007/s11306-013-0533-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Merlen G, Bidault‐jourdainne V, Kahale N, Glenisson M, Ursic‐bedoya J, Doignon I, Garcin I, Humbert L, Rainteau D, Tordjmann T. Hepatoprotective impact of the bile acid receptor TGR5. Liver Int 2020;40:1005-15. [DOI: 10.1111/liv.14427] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
35 Ananthanarayanan M. Therapy for hepatocyte transporter trafficking mutations: The time is now. Hepatology 2007;45:1340-2. [DOI: 10.1002/hep.21780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Lionarons DA, Heger M, van Golen RF, Alles LK, van der Mark VA, Kloek JJ, de Waart DR, Marsman HA, Rusch H, Verheij J, Beuers U, Paulusma CC, van Gulik TM. Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transport. Sci Rep 2016;6:31829. [PMID: 27535001 DOI: 10.1038/srep31829] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
37 de Graaf W, Häusler S, Heger M, van Ginhoven TM, van Cappellen G, Bennink RJ, Kullak-Ublick GA, Hesselmann R, van Gulik TM, Stieger B. Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green. J Hepatol. 2011;54:738-745. [PMID: 21163547 DOI: 10.1016/j.jhep.2010.07.047] [Cited by in Crossref: 156] [Cited by in F6Publishing: 141] [Article Influence: 13.0] [Reference Citation Analysis]
38 Mooranian A, Negrulj R, Takechi R, Mamo J, Al-Sallami H, Al-Salami H. The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects. Drug Deliv Transl Res 2018;8:543-51. [PMID: 29313296 DOI: 10.1007/s13346-017-0473-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
39 De Marino S, Ummarino R, D'Auria MV, Chini MG, Bifulco G, D'Amore C, Renga B, Mencarelli A, Petek S, Fiorucci S, Zampella A. 4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. Steroids 2012;77:484-95. [PMID: 22285937 DOI: 10.1016/j.steroids.2012.01.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
40 Xue X, Shi Z, Wang W, Yu X, Feng P, Zhang M, Wang X, Xu J. Huqi San-Evoked Rat Colonic Anion Secretion through Increasing CFTR Expression. Evid Based Complement Alternat Med 2015;2015:301640. [PMID: 26290673 DOI: 10.1155/2015/301640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
41 Razori MV, Maidagan PM, Ciriaci N, Andermatten RB, Barosso IR, Martín PL, Basiglio CL, Sánchez Pozzi EJ, Ruiz ML, Roma MG. Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis. Biochemical Pharmacology 2019;168:48-56. [DOI: 10.1016/j.bcp.2019.06.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
42 Macias RIR, Hierro C, Cuesta de Juan S, Jimenez F, Gonzalez-san Martin F, Marin JJG. Hepatic expression of sodium-dependent vitamin C transporters: ontogeny, subtissular distribution and effect of chronic liver diseases. Br J Nutr 2011;106:1814-25. [DOI: 10.1017/s0007114511002273] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
43 Yuan Z, Wang G, Qu J, Wang X, Li K. 9-cis-retinoic acid elevates MRP3 expression by inhibiting sumoylation of RXRα to alleviate cholestatic liver injury. Biochem Biophys Res Commun 2018;503:188-94. [PMID: 29885283 DOI: 10.1016/j.bbrc.2018.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
44 Perez MJ, Gonzalez-Sanchez E, Gonzalez-Loyola A, Gonzalez-Buitrago JM, Marin JJ. Mitochondrial genome depletion dysregulates bile acid- and paracetamol-induced expression of the transporters Mdr1, Mrp1 and Mrp4 in liver cells. Br J Pharmacol 2011;162:1686-99. [PMID: 21175587 DOI: 10.1111/j.1476-5381.2010.01174.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
45 Kroll T, Prescher M, Smits SHJ, Schmitt L. Structure and Function of Hepatobiliary ATP Binding Cassette Transporters. Chem Rev 2021;121:5240-88. [PMID: 33201677 DOI: 10.1021/acs.chemrev.0c00659] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
46 Dolezelova E, Prasnicka A, Cermanova J, Carazo A, Hyrsova L, Hroch M, Mokry J, Adamcova M, Mrkvicova A, Pavek P, Micuda S. Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats. World J Gastroenterol 2017; 23(43): 7678-7692 [PMID: 29209109 DOI: 10.3748/wjg.v23.i43.7678] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
47 Sticova E, Jirsa M. New insights in bilirubin metabolism and their clinical implications. World J Gastroenterol 2013; 19(38): 6398-6407 [PMID: 24151358 DOI: 10.3748/wjg.v19.i38.6398] [Cited by in CrossRef: 95] [Cited by in F6Publishing: 68] [Article Influence: 10.6] [Reference Citation Analysis]
48 Liang R, Ge W, Li B, Cui W, Ma X, Pan Y, Li G. Evodiamine decreased the systemic exposure of pravastatin in non-alcoholic steatohepatitis rats due to the up-regulation of hepatic OATPs. Pharm Biol 2022;60:359-73. [PMID: 35171063 DOI: 10.1080/13880209.2022.2036767] [Reference Citation Analysis]
49 Ozaki M. Cellular and molecular mechanisms of liver regeneration: Proliferation, growth, death and protection of hepatocytes. Semin Cell Dev Biol 2020;100:62-73. [PMID: 31669133 DOI: 10.1016/j.semcdb.2019.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
50 Mottino AD, Catania VA. Hepatic drug transporters and nuclear receptors: Regulation by therapeutic agents. World J Gastroenterol 2008; 14(46): 7068-7074 [PMID: 19084913 DOI: 10.3748/wjg.14.7068] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
51 Tang X, Zhao H, Jiang W, Zhang S, Guo S, Gao X, Yang P, Shi L, Liu L. Pharmacokinetics and pharmacodynamics of citrus peel extract in lipopolysaccharide-induced acute lung injury combined with Pinelliae Rhizoma Praeparatum. Food Funct 2018;9:5880-90. [DOI: 10.1039/c8fo01337c] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
52 Péan N, Doignon I, Garcin I, Besnard A, Julien B, Liu B, Branchereau S, Spraul A, Guettier C, Humbert L. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice. Hepatology. 2013;58:1451-1460. [PMID: 23686672 DOI: 10.1002/hep.26463] [Cited by in Crossref: 114] [Cited by in F6Publishing: 105] [Article Influence: 12.7] [Reference Citation Analysis]
53 Létourneau D, Lorin A, Lefebvre A, Cabana J, Lavigne P, LeHoux JG. Thermodynamic and solution state NMR characterization of the binding of secondary and conjugated bile acids to STARD5. Biochim Biophys Acta 2013;1831:1589-99. [PMID: 23872533 DOI: 10.1016/j.bbalip.2013.07.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
54 Xu JY, Li ZP, Zhang L, Ji G. Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(37): 13493-13500 [PMID: 25309079 DOI: 10.3748/wjg.v20.i37.13493] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
55 Kadova Z, Dolezelova E, Cermanova J, Hroch M, Laho T, Muchova L, Staud F, Vitek L, Mokry J, Chladek J, Havlinova Z, Holecek M, Micuda S. IL-1 receptor blockade alleviates endotoxin-mediated impairment of renal drug excretory functions in rats. American Journal of Physiology-Renal Physiology 2015;308:F388-99. [DOI: 10.1152/ajprenal.00266.2014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
56 Kriegermeier A, Green R. Pediatric Cholestatic Liver Disease: Review of Bile Acid Metabolism and Discussion of Current and Emerging Therapies. Front Med (Lausanne) 2020;7:149. [PMID: 32432119 DOI: 10.3389/fmed.2020.00149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
57 Deferm N, De Vocht T, Qi B, Van Brantegem P, Gijbels E, Vinken M, de Witte P, Bouillon T, Annaert P. Current insights in the complexities underlying drug-induced cholestasis. Crit Rev Toxicol 2019;49:520-48. [PMID: 31589080 DOI: 10.1080/10408444.2019.1635081] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
58 Bechmann LP, Kocabayoglu P, Sowa JP, Sydor S, Best J, Schlattjan M, Beilfuss A, Schmitt J, Hannivoort RA, Kilicarslan A, Rust C, Berr F, Tschopp O, Gerken G, Friedman SL, Geier A, Canbay A. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis. Hepatology. 2013;57:1394-1406. [PMID: 23299969 DOI: 10.1002/hep.26225] [Cited by in Crossref: 127] [Cited by in F6Publishing: 126] [Article Influence: 14.1] [Reference Citation Analysis]
59 Geier A, Dietrich CG, Trauner M, Gartung C. Extrahepatic cholestasis downregulates Oatp1 by TNF-? signalling without affecting Oatp2 and Oatp4 expression and sodium-independent bile salt uptake in rat liver. Liver Int 2007;27:1056-65. [DOI: 10.1111/j.1478-3231.2007.01523.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
60 Chen HL, Wu SH, Hsu SH, Liou BY, Chen HL, Chang MH. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases. J Biomed Sci 2018;25:75. [PMID: 30367658 DOI: 10.1186/s12929-018-0475-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
61 Ivashkin VT, Baranovsky AY, Raikhelson KL, Palgova LK, Maevskaya MV, Kondrashina EA, Marchenko NV, Nekrasova TP, Nikitin IG. Drug-Induced Liver Injuries (Clinical Guidelines for Physicians). Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2019;29:101-31. [DOI: 10.22416/1382-4376-2019-29-1-101-131] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
62 Merlen G, Ursic-Bedoya J, Jourdainne V, Kahale N, Glenisson M, Doignon I, Rainteau D, Tordjmann T. Bile acids and their receptors during liver regeneration: "Dangerous protectors". Mol Aspects Med. 2017;56:25-33. [PMID: 28302491 DOI: 10.1016/j.mam.2017.03.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
63 Rassam F, Olthof PB, Takkenberg BR, Beuers U, Klümpen HJ, Bennink RJ, van Lienden KP, Besselink MG, Busch OR, Verheij J, van Gulik TM. Scintigraphic liver function and transient elastography in the assessment of patients with resectable hepatocellular carcinoma. HPB (Oxford) 2019;21:626-35. [PMID: 30366883 DOI: 10.1016/j.hpb.2018.09.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
64 Liao MZ, Gao C, Bhatt DK, Prasad B, Mao Q. Quantitative Proteomics Reveals Changes in Transporter Protein Abundance in Liver, Kidney and Brain of Mice by Pregnancy. Drug Metab Lett 2018;12:145-52. [PMID: 29938623 DOI: 10.2174/1872312812666180625122810] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
65 Dietrich CG, Götze O, Geier A. Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance. World J Gastroenterol 2016; 22(1): 72-88 [PMID: 26755861 DOI: 10.3748/wjg.v22.i1.72] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
66 Xu S, Weerachayaphorn J, Cai SY, Soroka CJ, Boyer JL. Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression. Am J Physiol Gastrointest Liver Physiol 2010;299:G126-35. [PMID: 20395535 DOI: 10.1152/ajpgi.00522.2010] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 5.2] [Reference Citation Analysis]
67 Wagner M, Zollner G, Trauner M. New molecular insights into the mechanisms of cholestasis. J Hepatol. 2009;51:565-580. [PMID: 19595470 DOI: 10.1016/j.jhep.2009.05.012] [Cited by in Crossref: 164] [Cited by in F6Publishing: 145] [Article Influence: 12.6] [Reference Citation Analysis]
68 Yagi S, Hirabayashi K, Sato S, Li W, Takahashi Y, Hirakawa T, Wu G, Hattori N, Hattori N, Ohgane J, Tanaka S, Liu XS, Shiota K. DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) in mouse promoter regions demonstrating tissue-specific gene expression. Genome Res 2008;18:1969-78. [PMID: 18971312 DOI: 10.1101/gr.074070.107] [Cited by in Crossref: 123] [Cited by in F6Publishing: 107] [Article Influence: 8.8] [Reference Citation Analysis]
69 Roma MG, Toledo FD, Boaglio AC, Basiglio CL, Crocenzi FA, Sánchez Pozzi EJ. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. Clin Sci (Lond). 2011;121:523-544. [PMID: 21854363 DOI: 10.1042/cs20110184] [Cited by in Crossref: 94] [Cited by in F6Publishing: 40] [Article Influence: 8.5] [Reference Citation Analysis]
70 Massafra V, Milona A, Vos HR, Ramos RJJ, Gerrits J, Willemsen ECL, Ramos Pittol JM, Ijssennagger N, Houweling M, Prinsen HCMT, Verhoeven-Duif NM, Burgering BMT, van Mil SWC. Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice. Gastroenterology 2017;152:1462-1476.e10. [PMID: 28130067 DOI: 10.1053/j.gastro.2017.01.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
71 Wagner M, Zollner G, Fickert P, Gumhold J, Silbert D, Fuchsbichler A, Gujral JS, Zatloukal K, Denk H, Jaeschke H, Trauner M. Hepatobiliary transporter expression in intercellular adhesion molecule 1 knockout and Fas receptor-deficient mice after common bile duct ligation is independent of the degree of inflammation and oxidative stress. Drug Metab Dispos 2007;35:1694-9. [PMID: 17576807 DOI: 10.1124/dmd.107.015610] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
72 Xu Y, Zhong PP, Tao YY. Metabolic profiling of endogenous bile acids: a novel method to assess hepatoprotective effect of Tanreqing capsule on carbon-tetrachloride-induced liver injury in rats. Chin J Nat Med 2018;16:271-83. [PMID: 29703327 DOI: 10.1016/S1875-5364(18)30057-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
73 Xie H, Zeng D, Chen X, Huo D, Liu L, Zhang D, Jin Q, Ke K, Hu M. Prediction on the risk population of idiosyncratic adverse reactions based on molecular docking with mutant proteins. Oncotarget 2017;8:95568-76. [PMID: 29221149 DOI: 10.18632/oncotarget.21509] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
74 Al-Shahwani NH, Sigalet DL. Pathophysiology, prevention, treatment, and outcomes of intestinal failure-associated liver disease. Pediatr Surg Int 2017;33:405-11. [PMID: 28028560 DOI: 10.1007/s00383-016-4042-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
75 Režen T. The impact of cholesterol and its metabolites on drug metabolism. Expert Opin Drug Metab Toxicol 2011;7:387-98. [PMID: 21320036 DOI: 10.1517/17425255.2011.558083] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
76 Kojovic D, Piquette-miller M. Regulation of Drug Transporters by Inflammation. Drug Metabolism in Diseases. Elsevier; 2017. pp. 59-89. [DOI: 10.1016/b978-0-12-802949-7.00003-1] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
77 Csanaky IL, Aleksunes LM, Tanaka Y, Klaassen CD. Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice. Am J Physiol Gastrointest Liver Physiol. 2009;297:G419-G433. [PMID: 19497955 DOI: 10.1152/ajpgi.90728.2008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
78 Wooton-Kee CR, Jain AK, Wagner M, Grusak MA, Finegold MJ, Lutsenko S, Moore DD. Elevated copper impairs hepatic nuclear receptor function in Wilson's disease. J Clin Invest 2015;125:3449-60. [PMID: 26241054 DOI: 10.1172/JCI78991] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 6.4] [Reference Citation Analysis]
79 Li M, Zhao Y, Humar A, Tevar AD, Hughes C, Venkataramanan R. Pharmacokinetics of drugs in adult living donor liver transplant patients: regulatory factors and observations based on studies in animals and humans. Expert Opin Drug Metab Toxicol 2016;12:231-43. [PMID: 26809188 DOI: 10.1517/17425255.2016.1139575] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
80 Roberts MS, Liu X, Zou Y, Siebert GA, Chang P, Whitehouse MW, Fletcher L, Crawford DH. Effect of adjuvant-induced systemic inflammation in rats on hepatic disposition kinetics of taurocholate. Am J Physiol Gastrointest Liver Physiol 2011;300:G130-6. [PMID: 21030608 DOI: 10.1152/ajpgi.00162.2010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
81 Cieślak A, Trottier J, Verreault M, Milkiewicz P, Vohl MC, Barbier O. N-3 Polyunsaturated Fatty Acids Stimulate Bile Acid Detoxification in Human Cell Models. Can J Gastroenterol Hepatol 2018;2018:6031074. [PMID: 29850457 DOI: 10.1155/2018/6031074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
82 Urman JM, Herranz JM, Uriarte I, Rullán M, Oyón D, González B, Fernandez-Urién I, Carrascosa J, Bolado F, Zabalza L, Arechederra M, Alvarez-Sola G, Colyn L, Latasa MU, Puchades-Carrasco L, Pineda-Lucena A, Iraburu MJ, Iruarrizaga-Lejarreta M, Alonso C, Sangro B, Purroy A, Gil I, Carmona L, Cubero FJ, Martínez-Chantar ML, Banales JM, Romero MR, Macias RIR, Monte MJ, Marín JJG, Vila JJ, Corrales FJ, Berasain C, Fernández-Barrena MG, Avila MA. Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach. Cancers (Basel) 2020;12:E1644. [PMID: 32575903 DOI: 10.3390/cancers12061644] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
83 Miszczuk GS, Banales JM, Zucchetti AE, Pisani GB, Boaglio AC, Saez E, Medina JF, Roma MG, Crocenzi FA. Adaptive downregulation of Cl-/HCO3- exchange activity in rat hepatocytes under experimental obstructive cholestasis. PLoS One 2019;14:e0212215. [PMID: 30789925 DOI: 10.1371/journal.pone.0212215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
84 Zhou SF. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica. 2008;38:802-832. [PMID: 18668431 DOI: 10.1080/00498250701867889] [Cited by in Crossref: 361] [Cited by in F6Publishing: 323] [Article Influence: 25.8] [Reference Citation Analysis]
85 Fiorucci S, Distrutti E, Bifulco G, D’auria MV, Zampella A. Marine sponge steroids as nuclear receptor ligands. Trends in Pharmacological Sciences 2012;33:591-601. [DOI: 10.1016/j.tips.2012.08.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
86 Jang M, Manz A, Volk T, Kleber A. Study of melatonin-mediated effects on various hepatic inflammatory responses stimulated by IL-6 in a new HepG2-on-a-chip platform. Biomed Microdevices 2018;20. [DOI: 10.1007/s10544-018-0300-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
87 Kosters A, White DD, Sun H, Thevananther S, Karpen SJ. Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha. J Hepatol 2009;51:898-908. [PMID: 19767119 DOI: 10.1016/j.jhep.2009.06.029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
88 Claudel T, Zollner G, Wagner M, Trauner M. Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2011;1812:867-78. [DOI: 10.1016/j.bbadis.2010.12.021] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
89 Alaei Faradonbeh F, Lastuvkova H, Cermanova J, Hroch M, Nova Z, Uher M, Hirsova P, Pavek P, Micuda S. Multidrug Resistance-Associated Protein 2 Deficiency Aggravates Estrogen-Induced Impairment of Bile Acid Metabolomics in Rats. Front Physiol 2022;13:859294. [DOI: 10.3389/fphys.2022.859294] [Reference Citation Analysis]
90 Graham SF, Rey NL, Ugur Z, Yilmaz A, Sherman E, Maddens M, Bahado-Singh RO, Becker K, Schulz E, Meyerdirk LK, Steiner JA, Ma J, Brundin P. Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson's Disease. Metabolites 2018;8:E71. [PMID: 30384419 DOI: 10.3390/metabo8040071] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
91 Marrone J, Tocchetti GN, Danielli M, Mottino AD, Marinelli RA. Improved hepatic MRP2/ABCC2 transport activity in LPS-induced cholestasis by aquaporin-1 gene transfer. Biochimie 2019;165:179-82. [PMID: 31377196 DOI: 10.1016/j.biochi.2019.07.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
92 Cermanova J, Kadova Z, Dolezelova E, Zagorova M, Safka V, Hroch M, Laho T, Holeckova M, Mokry J, Kovarikova P, Bures J, Sterba M, Micuda S. Deferoxamine but not dexrazoxane alleviates liver injury induced by endotoxemia in rats. Shock 2014;42:372-9. [PMID: 25140599 DOI: 10.1097/SHK.0000000000000210] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
93 Fevery J. Bilirubin in clinical practice: a review: Bilirubin in clinical practice. Liver International 2008;28:592-605. [DOI: 10.1111/j.1478-3231.2008.01716.x] [Cited by in Crossref: 142] [Cited by in F6Publishing: 104] [Article Influence: 10.1] [Reference Citation Analysis]
94 Simončič M, Režen T, Juvan P, Rozman D, Fazarinc G, Fievet C, Staels B, Horvat S. Obesity resistant mechanisms in the Lean polygenic mouse model as indicated by liver transcriptome and expression of selected genes in skeletal muscle. BMC Genomics 2011;12:96. [PMID: 21291556 DOI: 10.1186/1471-2164-12-96] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
95 Ortega-Alonso A, Stephens C, Lucena MI, Andrade RJ. Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury. Int J Mol Sci. 2016;17. [PMID: 27187363 DOI: 10.3390/ijms17050714] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
96 Fuchs M, Sanyal AJ. Sepsis and cholestasis. Clin Liver Dis 2008;12:151-72, ix. [PMID: 18242502 DOI: 10.1016/j.cld.2007.11.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
97 Klein CJ, Ravenis M, Kusenda C, Scavo L. Parenteral Nutrition–Associated Conjugated Hyperbilirubinemia in Hospitalized Infants. Journal of the American Dietetic Association 2010;110:1684-95. [DOI: 10.1016/j.jada.2010.08.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
98 Trauner M, Halilbasic E. Nuclear receptors as new perspective for the management of liver diseases. Gastroenterology. 2011;140:1120-1125.e1-12. [PMID: 21334334 DOI: 10.1053/j.gastro.2011.02.044] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 6.6] [Reference Citation Analysis]
99 Chen J, Terada T, Ogasawara K, Katsura T, Inui K. Adaptive responses of renal organic anion transporter 3 (OAT3) during cholestasis. Am J Physiol Renal Physiol. 2008;295:F247-F252. [PMID: 18480179 DOI: 10.1152/ajprenal.00139.2008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
100 Roma MG, Sanchez Pozzi EJ. Oxidative stress: A radical way to stop making bile. Annals of Hepatology 2008;7:16-33. [DOI: 10.1016/s1665-2681(19)31884-8] [Cited by in Crossref: 36] [Article Influence: 2.6] [Reference Citation Analysis]
101 Karadeniz G, Acikgoz S, Tekin IO, Tascýlar O, Gun BD, Cömert M. Oxidized low-density-lipoprotein accumulation is associated with liver fibrosis in experimental cholestasis. Clinics (Sao Paulo). 2008;63:531-540. [PMID: 18719767 DOI: 10.1590/S1807-59322008000400020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
102 Soroka CJ, Boyer JL. Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations. Mol Aspects Med. 2014;37:3-14. [PMID: 23685087 DOI: 10.1016/j.mam.2013.05.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
103 de Lima Toccafondo Vieira M, Tagliati CA. Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools. Expert Opin Drug Metab Toxicol 2014;10:581-97. [PMID: 24588537 DOI: 10.1517/17425255.2014.884069] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
104 Ihunnah CA, Jiang M, Xie W. Nuclear receptor PXR, transcriptional circuits and metabolic relevance. Biochim Biophys Acta. 2011;1812:956-963. [PMID: 21295138 DOI: 10.1016/j.bbadis.2011.01.014] [Cited by in Crossref: 131] [Cited by in F6Publishing: 125] [Article Influence: 11.9] [Reference Citation Analysis]
105 Guo C, LaCerte C, Edwards JE, Brouwer KR, Brouwer KLR. Farnesoid X Receptor Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux in Sandwich-Cultured Human Hepatocytes: Functional Evidence and Mechanisms. J Pharmacol Exp Ther 2018;365:413-21. [PMID: 29487110 DOI: 10.1124/jpet.117.246033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
106 Taneja I, Raju KSR, Wahajuddin M. Dietary Isoflavones as Modulators of Drug Metabolizing Enzymes and Transporters: Effect on Prescription Medicines. Critical Reviews in Food Science and Nutrition 2015;56:S95-S109. [DOI: 10.1080/10408398.2015.1045968] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
107 Licata A. Adverse drug reactions and organ damage: The liver. Eur J Intern Med. 2016;28:9-16. [PMID: 26827101 DOI: 10.1016/j.ejim.2015.12.017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
108 Muchova L, Vanova K, Suk J, Micuda S, Dolezelova E, Fuksa L, Cerny D, Farghali H, Zelenkova M, Lenicek M, Wong RJ, Vreman HJ, Vitek L. Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis. J Cell Mol Med 2015;19:924-33. [PMID: 25683492 DOI: 10.1111/jcmm.12401] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
109 Dawson PA, Lan T, Rao A. Bile acid transporters. J Lipid Res 2009;50:2340-57. [PMID: 19498215 DOI: 10.1194/jlr.R900012-JLR200] [Cited by in Crossref: 401] [Cited by in F6Publishing: 201] [Article Influence: 30.8] [Reference Citation Analysis]
110 Haritova AM, Rusenova NV, Rusenov AG, Schrickx J, Lashev LD, Fink-gremmels J. Effects of fluoroquinolone treatment on MDR1 and MRP2 mRNA expression in Escherichia coli -infected chickens. Avian Pathology 2008;37:465-70. [DOI: 10.1080/03079450802272945] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
111 Martínez-Fernández P, Hierro L, Jara P, Alvarez L. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1119-G1129. [PMID: 19228886 DOI: 10.1152/ajpgi.90371.2008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
112 Wang X, Zheng L, Wu J, Tang B, Zhang M, Zhu D, Lin X. Constitutive androstane receptor activation promotes bilirubin clearance in a murine model of alcoholic liver disease. Mol Med Rep 2017;15:3459-66. [PMID: 28393244 DOI: 10.3892/mmr.2017.6435] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
113 Li Y, Zhou J, Li T. Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment. Front Mol Biosci 2022;9:879817. [DOI: 10.3389/fmolb.2022.879817] [Reference Citation Analysis]
114 Bouezzedine F, Fardel O, Gripon P. Interleukin 6 inhibits HBV entry through NTCP down regulation. Virology. 2015;481:34-42. [PMID: 25765005 DOI: 10.1016/j.virol.2015.02.026] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
115 Arrese M, Macias RI, Briz O, Perez MJ, Marin JJ. Molecular pathogenesis of intrahepatic cholestasis of pregnancy. Expert Rev Mol Med. 2008;10:e9. [PMID: 18371245 DOI: 10.1017/s1462399408000628] [Cited by in Crossref: 61] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
116 Halilbasic E, Claudel T, Trauner M. Bile acid transporters and regulatory nuclear receptors in the liver and beyond. J Hepatol. 2013;58:155-168. [PMID: 22885388 DOI: 10.1016/j.jhep.2012.08.002] [Cited by in Crossref: 228] [Cited by in F6Publishing: 210] [Article Influence: 22.8] [Reference Citation Analysis]
117 Wauters J, Mesotten D, Van Zwam K, van Pelt J, Thiessen S, Dieudonné AS, Vander Borght S, Van den Berghe G, Wilmer A. The impact of resuscitated fecal peritonitis on the expression of the hepatic bile salt transporters in a porcine model. Shock 2010;34:508-16. [PMID: 20357697 DOI: 10.1097/SHK.0b013e3181dfc4b4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
118 de Graaf W, Bennink RJ, Heger M, Maas A, de Bruin K, van Gulik TM. Quantitative Assessment of Hepatic Function During Liver Regeneration in a Standardized Rat Model. J Nucl Med 2011;52:294-302. [DOI: 10.2967/jnumed.110.078360] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
119 Stieger B, Hagenbuch B. Organic anion-transporting polypeptides. Curr Top Membr. 2014;73:205-232. [PMID: 24745984 DOI: 10.1016/b978-0-12-800223-0.00005-0] [Cited by in Crossref: 84] [Cited by in F6Publishing: 33] [Article Influence: 10.5] [Reference Citation Analysis]
120 W Rivero C, Rosso N, Gentile E, Cuestas M, Tiribelli C, Oubiña JR, Mathet VL. Dissimilar expression of multidrug resistance mdr1 and bcrp by the replication of hepatitis C virus: role of the nonstructural 5A protein. J Viral Hepat 2013;20:e127-30. [PMID: 23490381 DOI: 10.1111/jvh.12028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
121 Arrese M, Karpen SJ. Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases. Clin Pharmacol Ther 2010;87:473-8. [PMID: 20200515 DOI: 10.1038/clpt.2010.2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
122 de Graaf W, Heger M, Spruijt O, Maas A, de Bruin K, Hoekstra R, Bennink RJ, van Gulik TM. Quantitative Assessment of Liver Function after Ischemia-Reperfusion Injury and Partial Hepatectomy in Rats. Journal of Surgical Research 2012;172:85-94. [DOI: 10.1016/j.jss.2010.06.038] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
123 Kosters A, Karpen SJ. Bile acid transporters in health and disease. Xenobiotica. 2008;38:1043-1071. [PMID: 18668439 DOI: 10.1080/00498250802040584] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 7.4] [Reference Citation Analysis]
124 Razori MV, Martín PL, Maidagan PM, Barosso IR, Ciriaci N, Andermatten RB, Sánchez Pozzi EJ, Basiglio CL, Ruiz ML, Roma MG. Spironolactone ameliorates lipopolysaccharide-induced cholestasis in rats by improving Mrp2 function: Role of transcriptional and post-transcriptional mechanisms. Life Sciences 2020;259:118352. [DOI: 10.1016/j.lfs.2020.118352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
125 Yamada T, Obata A, Kashiwagi Y, Rokugawa T, Matsushima S, Hamada T, Watabe H, Abe K. Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice. Magn Reson Imaging 2016;34:724-9. [PMID: 26979540 DOI: 10.1016/j.mri.2016.03.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
126 Armendariz AD, Krauss RM. Hepatic nuclear factor 1-alpha: inflammation, genetics, and atherosclerosis. Curr Opin Lipidol 2009;20:106-11. [PMID: 19280766 DOI: 10.1097/mol.0b013e3283295ee9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
127 Hagenbeck C, Hamza A, Kehl S, Maul H, Lammert F, Keitel V, Hütten MC, Pecks U. Management of Intrahepatic Cholestasis of Pregnancy: Recommendations of the Working Group on Obstetrics and Prenatal Medicine - Section on Maternal Disorders. Geburtshilfe Frauenheilkd 2021;81:922-39. [PMID: 34393256 DOI: 10.1055/a-1386-3912] [Reference Citation Analysis]
128 Ikebuchi Y, Takada T, Ito K, Yoshikado T, Anzai N, Kanai Y, Suzuki H. Receptor for activated C-kinase 1 regulates the cellular localization and function of ABCB4. Hepatol Res 2009;39:1091-107. [PMID: 19674157 DOI: 10.1111/j.1872-034X.2009.00544.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
129 Ghibellini G, Leslie EM, Pollack GM, Brouwer KL. Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies. Pharm Res 2008;25:1851-60. [PMID: 18509604 DOI: 10.1007/s11095-008-9597-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
130 Schadt HS, Wolf A, Pognan F, Chibout SD, Merz M, Kullak-Ublick GA. Bile acids in drug induced liver injury: Key players and surrogate markers. Clin Res Hepatol Gastroenterol 2016;40:257-66. [PMID: 26874804 DOI: 10.1016/j.clinre.2015.12.017] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 7.7] [Reference Citation Analysis]
131 Graham SF, Rey NL, Yilmaz A, Kumar P, Madaj Z, Maddens M, Bahado-Singh RO, Becker K, Schulz E, Meyerdirk LK, Steiner JA, Ma J, Brundin P. Biochemical Profiling of the Brain and Blood Metabolome in a Mouse Model of Prodromal Parkinson's Disease Reveals Distinct Metabolic Profiles. J Proteome Res 2018;17:2460-9. [PMID: 29762036 DOI: 10.1021/acs.jproteome.8b00224] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
132 Clausen MR, Zhang X, Yde CC, Ditlev DB, Lillefosse HH, Madsen L, Kristiansen K, Liaset B, Bertram HC. Intake of hydrolyzed casein is associated with reduced body fat accretion and enhanced phase II metabolism in obesity prone C57BL/6J mice. PLoS One 2015;10:e0118895. [PMID: 25738501 DOI: 10.1371/journal.pone.0118895] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
133 Koepsell H. Organic Cation Transporters in Health and Disease. Pharmacol Rev 2020;72:253-319. [PMID: 31852803 DOI: 10.1124/pr.118.015578] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 29.5] [Reference Citation Analysis]
134 Monte MJ, Marin JJ, Antelo A, Vazquez-Tato J. Bile acids: Chemistry, physiology, and pathophysiology. World J Gastroenterol 2009; 15(7): 804-816 [PMID: 19230041 DOI: 10.3748/wjg.15.804] [Cited by in CrossRef: 309] [Cited by in F6Publishing: 268] [Article Influence: 23.8] [Reference Citation Analysis]
135 Pollheimer MJ, Fickert P, Stieger B. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis. Mol Aspects Med. 2014;37:35-56. [PMID: 24141039 DOI: 10.1016/j.mam.2013.10.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
136 Pablo Arab J, Ramírez C, Muñoz P, Pizarro M, Solís N, Riquelme A, Arrese M. Effects of Japanese herbal medicine inchin-ko-to on endotoxin-induced cholestasis in the rat. Annals of Hepatology 2009;8:228-33. [DOI: 10.1016/s1665-2681(19)31770-3] [Cited by in Crossref: 10] [Article Influence: 0.8] [Reference Citation Analysis]
137 Kosters A, Karpen SJ. The role of inflammation in cholestasis: clinical and basic aspects. Semin Liver Dis. 2010;30:186-194. [PMID: 20422500 DOI: 10.1055/s-0030-1253227] [Cited by in Crossref: 110] [Cited by in F6Publishing: 95] [Article Influence: 9.2] [Reference Citation Analysis]
138 Park YJ, Qatanani M, Chua SS, LaRey JL, Johnson SA, Watanabe M, Moore DD, Lee YK. Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis. Hepatology 2008;47:1578-86. [PMID: 18393320 DOI: 10.1002/hep.22196] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 3.8] [Reference Citation Analysis]
139 Li M, Soroka CJ, Harry K, Boyer JL. CFTR-associated ligand is a negative regulator of Mrp2 expression. Am J Physiol Cell Physiol 2017;312:C40-6. [PMID: 27834195 DOI: 10.1152/ajpcell.00100.2016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
140 Hernandez JP, Mota LC, Baldwin WS. Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation. Curr Pharmacogenomics Person Med 2009;7:81-105. [PMID: 20871735 DOI: 10.2174/187569209788654005] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 6.6] [Reference Citation Analysis]
141 Iwakiri T, Okumura M, Matsunaga N, Ichihara E, Shiotsuki S, Nagata M, Kumagai Y, Kai H, Arimori K. Hepatocyte growth factor increases uptake of estradiol 17β-d-glucuronide and Oatp1 protein level in rat hepatocytes. European Journal of Pharmacology 2008;580:19-26. [DOI: 10.1016/j.ejphar.2007.10.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
142 Richter C, Seco J, Hong TS, Duda DG, Bortfeld T. Radiation-induced changes in hepatocyte-specific Gd-EOB-DTPA enhanced MRI: potential mechanism. Med Hypotheses 2014;83:477-81. [PMID: 25175713 DOI: 10.1016/j.mehy.2014.08.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
143 Ananthanarayanan M, Li Y, Surapureddi S, Balasubramaniyan N, Ahn J, Goldstein JA, Suchy FJ. Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis. Am J Physiol Gastrointest Liver Physiol. 2011;300:G771-G781. [PMID: 21330447 DOI: 10.1152/ajpgi.00499.2010] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
144 Kumar A, Kumar V, Rattan V, Jha V, Pal A, Bhattacharyya S. Molecular spectrum of secretome regulates the relative hepatogenic potential of mesenchymal stem cells from bone marrow and dental tissue. Sci Rep. 2017;7:15015. [PMID: 29118330 DOI: 10.1038/s41598-017-14358-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
145 Roma MG, Crocenzi FA, Sánchez Pozzi EA. Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects. Clin Sci (Lond) 2008;114:567-88. [PMID: 18377365 DOI: 10.1042/CS20070227] [Cited by in Crossref: 30] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
146 Watkins J, Klaassen C. Absorption, Enterohepatic Circulation, and Fecal Excretion of Toxicants. Comprehensive Toxicology. Elsevier; 2018. pp. 99-112. [DOI: 10.1016/b978-0-12-801238-3.02122-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
147 Fiorucci S, Mencarelli A, Distrutti E, Zampella A. Farnesoid X receptor: from medicinal chemistry to clinical applications. Future Med Chem 2012;4:877-91. [PMID: 22571613 DOI: 10.4155/fmc.12.41] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
148 Prasnicka A, Lastuvkova H, Alaei Faradonbeh F, Cermanova J, Hroch M, Mokry J, Dolezelova E, Pavek P, Zizalova K, Vitek L, Nachtigal P, Micuda S. Iron overload reduces synthesis and elimination of bile acids in rat liver. Sci Rep 2019;9:9780. [PMID: 31278332 DOI: 10.1038/s41598-019-46150-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
149 Le Vee M, Gripon P, Stieger B, Fardel O. Down-Regulation of Organic Anion Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokine Interleukin 1β. Drug Metab Dispos 2008;36:217-22. [DOI: 10.1124/dmd.107.016907] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 6.1] [Reference Citation Analysis]
150 Charoensuk L, Pinlaor P, Laothong U, Yongvanit P, Pairojkul C, Nawa Y, Pinlaor S. Bile canalicular changes and defective bile secretion in Opisthorchis viverrini-infected hamsters. FOLIA PARASIT 2014;61:512-22. [DOI: 10.14411/fp.2014.063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
151 Kobyliak N, Virchenko O, Falalyeyeva T. Pathophysiological role of host microbiota in the development of obesity. Nutr J. 2016;15:43. [PMID: 27105827 DOI: 10.1186/s12937-016-0166-9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 10.0] [Reference Citation Analysis]
152 Liu B, Li Y, Ji H, Lu H, Li H, Shi Y. Glutamine attenuates obstructive cholestasis in rats via farnesoid X receptor–mediated regulation of Bsep and Mrp2. Can J Physiol Pharmacol 2017;95:215-23. [DOI: 10.1139/cjpp-2016-0389] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
153 Cermanova J, Kadova Z, Zagorova M, Hroch M, Tomsik P, Nachtigal P, Kudlackova Z, Pavek P, Dubecka M, Ceckova M. Boldine enhances bile production in rats via osmotic and farnesoid X receptor dependent mechanisms. Toxicol Appl Pharmacol. 2015;285:12-22. [PMID: 25771127 DOI: 10.1016/j.taap.2015.03.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
154 Li S, Wang R, Wu B, Wang Y, Song F, Gu Y, Yuan Y. Salvianolic acid B protects against ANIT-induced cholestatic liver injury through regulating bile acid transporters and enzymes, and NF-κB/IκB and MAPK pathways. Naunyn Schmiedebergs Arch Pharmacol 2019;392:1169-80. [PMID: 31098695 DOI: 10.1007/s00210-019-01657-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
155 Jemnitz K, Veres Z, Szabo M, Baranyai Z, Jakab F, Vereczkey L. Differential inhibitory effect of cyclosporin A and bosentan on taurocholate uptake in human and rat hepatocytes as a function of culturing time. Toxicol In Vitro. 2012;26:174-181. [PMID: 22119333 DOI: 10.1016/j.tiv.2011.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
156 Flowers MT, Keller MP, Choi Y, Lan H, Kendziorski C, Ntambi JM, Attie AD. Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet. Physiological Genomics 2008;33:361-72. [DOI: 10.1152/physiolgenomics.00139.2007] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 4.4] [Reference Citation Analysis]
157 Stieger B. Recent insights into the function and regulation of the bile salt export pump (ABCB11). Current Opinion in Lipidology 2009;20:176-81. [DOI: 10.1097/mol.0b013e32832b677c] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
158 Ghoneim RH, Piquette-Miller M. Endotoxin-Mediated Downregulation of Hepatic Drug Transporters in HIV-1 Transgenic Rats. Drug Metab Dispos 2016;44:709-19. [PMID: 26977098 DOI: 10.1124/dmd.115.067827] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
159 Dunn KW, Ryan JC. Using quantitative intravital multiphoton microscopy to dissect hepatic transport in rats. Methods 2017;128:40-51. [PMID: 28434905 DOI: 10.1016/j.ymeth.2017.04.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
160 Schmitt J, Roderfeld M, Sabrane K, Zhang P, Tian Y, Mertens JC, Frei P, Stieger B, Weber A, Müllhaupt B, Roeb E, Geier A. Complement factor C5 deficiency significantly delays the progression of biliary fibrosis in bile duct-ligated mice. Biochem Biophys Res Commun 2012;418:445-50. [PMID: 22277671 DOI: 10.1016/j.bbrc.2012.01.036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
161 Gyamfi MA, Wan YJ. Mechanisms of resistance of hepatocyte retinoid X receptor alpha-null mice to WY-14,643-induced hepatocyte proliferation and cholestasis. J Biol Chem 2009;284:9321-30. [PMID: 19176532 DOI: 10.1074/jbc.M808861200] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
162 Stahl S, Davies MR, Cook DI, Graham MJ. Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis. Xenobiotica 2008;38:725-77. [DOI: 10.1080/00498250802105593] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
163 Gonzalez FJ. Nuclear receptor control of enterohepatic circulation. Compr Physiol 2012;2:2811-28. [PMID: 23720266 DOI: 10.1002/cphy.c120007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
164 Meyer Zu Schwabedissen HE, Böttcher K, Chaudhry A, Kroemer HK, Schuetz EG, Kim RB. Liver X receptor α and farnesoid X receptor are major transcriptional regulators of OATP1B1. Hepatology 2010;52:1797-807. [PMID: 20827719 DOI: 10.1002/hep.23876] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
165 Bala L, Tripathi P, Bhatt G, Das K, Roy R, Choudhuri G, Khetrapal CL. (1)H and (31)P NMR studies indicate reduced bile constituents in patients with biliary obstruction and infection. NMR Biomed 2009;22:220-8. [PMID: 18837066 DOI: 10.1002/nbm.1308] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
166 Banach B, Modrzejewski A, Juzyszyn Z, Kurzawski M, Sroczynski T, Pawlik A. Association Study of SLCO1B3 and ABCC3 Genetic Variants in Gallstone Disease. Genes 2022;13:512. [DOI: 10.3390/genes13030512] [Reference Citation Analysis]
167 Freudenberg F, Leonard MR, Liu SA, Glickman JN, Carey MC. Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol 2010;299:G205-14. [PMID: 20430874 DOI: 10.1152/ajpgi.00341.2009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
168 Dawson PA, Lan T, Rao A. Bile acid transporters. J Lipid Res. 2009;50:2340-2357. [PMID: 19498215 DOI: 10.1194/jlr.r900012-jlr2001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
169 Fardel O, Le Vée M. Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines. Expert Opinion on Drug Metabolism & Toxicology 2009;5:1469-81. [DOI: 10.1517/17425250903304056] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
170 Lian W, Liu X, Chen W. TNFα Induces Multidrug Resistance-Associated Protein 4 Expression through p38-E2F1-Nrf2 Signaling in Obstructive Cholestasis. Yonsei Med J 2019;60:1045-53. [PMID: 31637886 DOI: 10.3349/ymj.2019.60.11.1045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
171 Stieger B. Role of the bile salt export pump, BSEP, in acquired forms of cholestasis. Drug Metab Rev. 2010;42:437-445. [PMID: 20028269 DOI: 10.3109/03602530903492004] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 7.3] [Reference Citation Analysis]
172 Dietrich CG, Rau M, Jahn D, Geier A. Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease. Expert Opin Drug Metab Toxicol 2017;13:625-40. [PMID: 28359183 DOI: 10.1080/17425255.2017.1314461] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
173 Martin IV, Schmitt J, Minkenberg A, Mertens JC, Stieger B, Mullhaupt B, Geier A. Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice. Biol Chem. 2010;391:1441-1449. [PMID: 20868235 DOI: 10.1515/bc.2010.141] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
174 Fisher CD, Lickteig AJ, Augustine LM, Oude Elferink RP, Besselsen DG, Erickson RP, Cherrington NJ. Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats. Eur J Pharmacol. 2009;613:119-127. [PMID: 19358839 DOI: 10.1016/j.ejphar.2009.04.002] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 5.7] [Reference Citation Analysis]
175 Zhao G, Xu D, Yuan Z, Jiang Z, Zhou W, Li Z, Yin M, Zhou Z, Zhang L, Wang T. 8-Methoxypsoralen disrupts MDR3-mediated phospholipids efflux and bile acid homeostasis and its relevance to hepatotoxicity. Toxicology 2017;386:40-8. [PMID: 28552422 DOI: 10.1016/j.tox.2017.05.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
176 Kushnareva NS, Smirnova OV. Effect of Prolactin on Excretory Function of the Liver during the Induction and Relief of Cholestasis in Female Rats. Bull Exp Biol Med 2009;148:758-61. [DOI: 10.1007/s10517-010-0810-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
177 Portincasa P, Di Ciaula A, Garruti G, Vacca M, De Angelis M, Wang DQ. Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome. Nutrients 2020;12:E3709. [PMID: 33266235 DOI: 10.3390/nu12123709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
178 Morgan RE, Trauner M, van Staden CJ, Lee PH, Ramachandran B, Eschenberg M, Afshari CA, Qualls CW Jr, Lightfoot-Dunn R, Hamadeh HK. Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci. 2010;118:485-500. [PMID: 20829430 DOI: 10.1093/toxsci/kfq269] [Cited by in Crossref: 243] [Cited by in F6Publishing: 205] [Article Influence: 20.3] [Reference Citation Analysis]
179 Schmitt J, Kong B, Stieger B, Tschopp O, Schultze SM, Rau M, Weber A, Müllhaupt B, Guo GL, Geier A. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal. Liver Int. 2015;35:1133-1144. [PMID: 25156247 DOI: 10.1111/liv.12456] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 7.5] [Reference Citation Analysis]
180 Geier A. Hepatitis B virus: the “metabolovirus” highjacks cholesterol and bile acid metabolism. Hepatology. 2014;60:1458-1460. [PMID: 24829054 DOI: 10.1002/hep.27224] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
181 Gu X, Manautou JE. Molecular mechanisms underlying chemical liver injury. Expert Rev Mol Med 2012;14:e4. [PMID: 22306029 DOI: 10.1017/S1462399411002110] [Cited by in Crossref: 109] [Cited by in F6Publishing: 48] [Article Influence: 10.9] [Reference Citation Analysis]
182 Tomsik P, Sispera L, Rezacova M, Niang M, Stoklasova A, Cerman J, Knizek J, Brcakova E, Cermanova J, Micuda S. Increased melibiose/rhamnose ratio in bile of rats with acute cholestasis. Journal of Gastroenterology and Hepatology 2008;23:1934-40. [DOI: 10.1111/j.1440-1746.2008.05505.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
183 Stieger B. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handb Exp Pharmacol. 2011;205-259. [PMID: 21103971 DOI: 10.1007/978-3-642-14541-4_5] [Cited by in Crossref: 170] [Cited by in F6Publishing: 159] [Article Influence: 15.5] [Reference Citation Analysis]
184 Vivian D, Polli JE. Synthesis and in vitro evaluation of bile acid prodrugs of floxuridine to target the liver. Int J Pharm 2014;475:597-604. [PMID: 25219859 DOI: 10.1016/j.ijpharm.2014.09.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
185 Yuan ZQ, Li KW. Role of farnesoid X receptor in cholestasis. J Dig Dis 2016;17:501-9. [PMID: 27383832 DOI: 10.1111/1751-2980.12378] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
186 Hamazaki J, Hirayama S, Murata S. Redundant Roles of Rpn10 and Rpn13 in Recognition of Ubiquitinated Proteins and Cellular Homeostasis. PLoS Genet 2015;11:e1005401. [PMID: 26222436 DOI: 10.1371/journal.pgen.1005401] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 7.6] [Reference Citation Analysis]
187 Zollner G, Trauner M. Mechanisms of cholestasis. Clin Liver Dis. 2008;12:1-26, vii. [PMID: 18242495 DOI: 10.1016/j.cld.2007.11.010] [Cited by in Crossref: 113] [Cited by in F6Publishing: 99] [Article Influence: 8.1] [Reference Citation Analysis]
188 Kolouchova G, Brcakova E, Hirsova P, Sispera L, Tomsik P, Cermanova J, Hyspler R, Slanarova M, Fuksa L, Lotkova H. Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis. J Gastroenterol Hepatol. 2011;26:1544-1551. [PMID: 21501227 DOI: 10.1111/j.1440-1746.2011.06748.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
189 Cortez L, Sim V. The therapeutic potential of chemical chaperones in protein folding diseases. Prion 2014;8:28938. [PMID: 24818993 DOI: 10.4161/pri.28938] [Cited by in Crossref: 117] [Cited by in F6Publishing: 96] [Article Influence: 14.6] [Reference Citation Analysis]
190 Erdmann P, Bruckmueller H, Martin P, Busch D, Haenisch S, Müller J, Wiechowska-kozlowska A, Partecke LI, Heidecke C, Cascorbi I, Drozdzik M, Oswald S. Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis. Journal of Pharmaceutical Sciences 2019;108:1035-46. [DOI: 10.1016/j.xphs.2018.09.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
191 Yang K, Köck K, Sedykh A, Tropsha A, Brouwer KL. An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters. J Pharm Sci 2013;102:3037-57. [PMID: 23653385 DOI: 10.1002/jps.23584] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 7.9] [Reference Citation Analysis]
192 Dietrich CG, Geier A. Effect of drug transporter pharmacogenetics on cholestasis. Expert Opin Drug Metab Toxicol. 2014;10:1533-1551. [PMID: 25260651 DOI: 10.1517/17425255.2014.963553] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
193 Balasubramaniyan N, Ananthanarayanan M, Suchy FJ. Nuclear factor-κB regulates the expression of multiple genes encoding liver transport proteins. Am J Physiol Gastrointest Liver Physiol 2016;310:G618-28. [PMID: 26867564 DOI: 10.1152/ajpgi.00363.2015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
194 Tan KP, Wood GA, Yang M, Ito S. Participation of nuclear factor (erythroid 2-related), factor 2 in ameliorating lithocholic acid-induced cholestatic liver injury in mice. Br J Pharmacol. 2010;161:1111-1121. [PMID: 20977460 DOI: 10.1111/j.1476-5381.2010.00953.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
195 Stieger B, Unadkat JD, Prasad B, Langer O, Gali H. Role of (drug) transporters in imaging in health and disease. Drug Metab Dispos 2014;42:2007-15. [PMID: 25249691 DOI: 10.1124/dmd.114.059873] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
196 Terui K, Saito T, Hishiki T, Sato Y, Mitsunaga T, Yoshida H. Hepatic expression of multidrug resistance protein 2 in biliary atresia. Comp Hepatol 2011;10:6. [PMID: 21813008 DOI: 10.1186/1476-5926-10-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
197 Chiarla C, Giovannini I, Giuliante F, Vellone M, Ardito F, Masi A, Nuzzo G. Plasma bilirubin correlations in non-obstructive cholestasis after partial hepatectomy. Clin Chem Lab Med 2008;46:1598-601. [PMID: 19012524 DOI: 10.1515/CCLM.2008.321] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
198 Drozdzik M, Szelag‐pieniek S, Post M, Zeair S, Wrzesinski M, Kurzawski M, Prieto J, Oswald S. Protein Abundance of Hepatic Drug Transporters in Patients With Different Forms of Liver Damage. Clin Pharmacol Ther 2020;107:1138-48. [DOI: 10.1002/cpt.1717] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
199 Donepudi AC, Aleksunes LM, Driscoll MV, Seeram NP, Slitt AL. The traditional ayurvedic medicine, Eugenia jambolana (Jamun fruit), decreases liver inflammation, injury and fibrosis during cholestasis. Liver Int 2012;32:560-73. [PMID: 22212619 DOI: 10.1111/j.1478-3231.2011.02724.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
200 Jansen PL, Ghallab A, Vartak N, Reif R, Schaap FG, Hampe J, Hengstler JG. The ascending pathophysiology of cholestatic liver disease. Hepatology 2016;65:722-38. [DOI: 10.1002/hep.28965] [Cited by in Crossref: 122] [Cited by in F6Publishing: 119] [Article Influence: 24.4] [Reference Citation Analysis]
201 Rao ZZ, Zhang XW, Ding YL, Yang MY. miR-148a-mediated estrogen-induced cholestasis in intrahepatic cholestasis of pregnancy: Role of PXR/MRP3. PLoS One 2017;12:e0178702. [PMID: 28575098 DOI: 10.1371/journal.pone.0178702] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
202 Schaap FG, van der Gaag NA, Gouma DJ, Jansen PL. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Hepatology 2009;49:1228-35. [PMID: 19185005 DOI: 10.1002/hep.22771] [Cited by in Crossref: 192] [Cited by in F6Publishing: 185] [Article Influence: 14.8] [Reference Citation Analysis]
203 Mann A, Semenenko I, Meir M, Eyal S. Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes. AAPS J 2015;17:788-801. [PMID: 25823669 DOI: 10.1208/s12248-015-9752-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
204 Mertens PR, Martin IV, Frye BC, Rauen T, Strauch S, Pabst M, Geier A. Rat Mrp2 gene expression is regulated by an interleukin-1β-stimulated biphasic response with enhanced transcription and subcellular shuttling of YB-1. Eur J Cell Biol 2012;91:533-41. [PMID: 22361279 DOI: 10.1016/j.ejcb.2011.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
205 Sun Y, Haapanen K, Li B, Zhang W, Van de Water J, Gershwin ME. Women and primary biliary cirrhosis. Clin Rev Allergy Immunol 2015;48:285-300. [PMID: 25241227 DOI: 10.1007/s12016-014-8449-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
206 Tian Y, Cai J, Gui W, Nichols RG, Koo I, Zhang J, Anitha M, Patterson AD. Berberine Directly Affects the Gut Microbiota to Promote Intestinal Farnesoid X Receptor Activation. Drug Metab Dispos. 2019;47:86-93. [PMID: 30409838 DOI: 10.1124/dmd.118.083691] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
207 Magnol L, Chevallier MC, Nalesso V, Retif S, Fuchs H, Klempt M, Pereira P, Riottot M, Andrzejewski S, Doan BT, Panthier JJ, Puech A, Beloeil JC, de Angelis MH, Hérault Y. KIT is required for hepatic function during mouse post-natal development. BMC Dev Biol 2007;7:81. [PMID: 17612398 DOI: 10.1186/1471-213X-7-81] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]